Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease

Human Molecular Genetics

Volumn 14, Issue 15, 2005, Pages 2099-2111

  Strauss, Karsten M ^a   Martins, L Miguel ^d   Plun Favreau, Helene ^e   Marx, Frank P ^a   Kautzmann, Sabine ^a   Berg, Daniela ^a,b   Gasser, Thomas ^a   Wszolek, Zbginiew ^f   Müller, Thomas ^g   Bornemann, Antje ^b   Wolburg, Hartwig ^c   Downward, Julian ^e   Riess, Olaf ^b   Schulz, Jörg B ^a,h   Krüger, Rejko ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d MRC TOXICOLOGY UNIT   (United Kingdom)

^e IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^f MAYO CLINIC   (United States)

^g RUHR UNIVERSITY BOCHUM   (Germany)

^h UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLYCINE; MUTANT PROTEIN; PROTEINASE; SERINE; SERINE PROTEINASE OMI;

ALLELE; ARTICLE; CELL DEATH; CELL STRUCTURE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVATION; ENZYME ACTIVITY; FUNCTIONAL GENOMICS; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; GERMANY; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NERVE DEGENERATION; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STRESS; WILD TYPE;

PARKINSONIA;

EID: 25444498785     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddi215     Document Type: Article

References (31)

1. Beal, M.F. (2000) Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci., 22, 298-304.
2. Schapira, A.H. (1999) Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia. Biochim. Biophys. Acta, 1410, 159-170.
3. Hegde, R., Srinivasula, S.M., Zhang, Z., Wassell, R., Mukattash, R., Cilenti, L., DuBois, G., Lazebnik, Y., Zervos, A.S., Fernandes-Alnemri, T. et al. (2002) Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem., 277, 432-438.
4. Martins, L.M., Iaccarino, I., Tenev, T., Gschmeissner, S., Totty, N.F., Lemoine, N.R., Savopoulos, J., Gray, C.W., Creasy, C.L., Dingwall, C. et al. (2002) The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J. Biol. Chem., 277 439-444.
5. Suzuki, Y., Imai, Y., Nakayama, H., Takahashi, K., Takio, K. and Takahashi, R. (2001) A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell 8, 613-621.
6. Verhagen, A.M., Silke, J., Ekert, P.G., Pakusch, M., Kaufmann, H., Connolly, L.M., Day, C.L., Tikoo, A., Burke, R., Wrobel, C. et al. (2002) HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J. Biol. Chem., 277, 445-454.
7. Martins, L.M., Turk, B.E., Cowling, V., Borg, A., Jarrell, E.T., Cantley, L.C. and Downward, J. (2003) Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Oml. J. Biol. Chem. 278, 49417-49427.
8. Walsh, N.P., Alba, B.M., Bose, B., Gross, C.A. and Sauer, R.T. (2003) OMP peptide signals initiate the envelope-stress response by activating DegS protease via relief of inhibition mediated by its PDZ. domain. Cell, 113, 61-71.
9. Wilken, C., Kitzing, K., Kurzbauer, R., Ehrmann, M. and Clausen, T. (2004) Crystal structure of the DegS stress sensor: How a PDZ domain recognizes misfolded protein and activates a protease. Cell, 117, 483-494.
10. Gray, C.W., Ward, R.V., Karran, E., Turconi, S., Rowles, A., Viglienghi, D., Southan, C., Barton, A., Fantom, K.G., West, A. et al. (2000) Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur. J. Biochem., 267, 5699-5710.
11. Gupta, S., Singh, R., Datta, P., Zhang, Z., Orr, C., Lu, Z., DuBois, G., Zervos, A.S., Meister, M.H., Srinivasula, S.M. et al. (2004) The carboxy terminal tail of presenilin regulates Omi/HtrA2 protease activity. J. Biol. Chem., 279, 45844-45854.
12. Park, H.J., Seong, Y.M., Choi, J.Y., Yang, S. and Rhim, H. (2004) Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi. Neurosci. Lett., 357, 63-67.
13. Jones, J.M., Datta, P., Srinivasula, S.M., Ji, W., Gupta, S., Zhang, Z., Davies, E., Hajnoczky, G., Saunders, T.L., van Keuren, M.L. et al. (2003) Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature, 425, 721-727.
14. Martins, L.M., Morrison, A., Klupsch, K., Fedele, V., Moisoi, N., Teismann, P., Abuin, A., Grau, E., Geppert, M., Livi, G.P. et al. (2004) Neuroprotective role of the Reaper-related serine protease HtrA2/ Omi revealed by targeted deletion in mice. Mol. Cell Biol., 24 9848-9862.
15. Gasser, T., Muller-Myhsok, B., Wszolek, Z.K., Oehlmann, R., Calne, D.B., Bonifati, V., Bereznai, B., Fabrizio, E., Vieregge, P. and Horstmann, R.D. (1998) A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat. Genet., 18, 262-265.
16. DeStefano, A.L., Lew, M.F., Golbe, L.I., Mark, M.H., Lazzarini, A.M., Guttman, M., Montgomery, E., Waters, C.H., Singer, C., Watts, R.L. et al. (2002) PARK3 influences age at onset in Parkinson's disease: A genome scan in the GenePD study. Am. J. Hum. Genet., 70, 1089-1095.
17. Karamohamed, S., DeStefano, A.L., Wilk, J.B., Shoemaker, C.M., Golbe, L.I., Mark, M.H., Lazzarini, A.M., Suchowersky, O., Labelle, N., Guttman, M. et al. (2003) A haplotype at the PARK3 locus influences onset age for Parkinson's disease: The GenePD study. Neurology, 61, 1557-1561.
18. Pankratz, N., Uniacke, S.K., Halter, C.A., Rudolph, A., Shults, C.W., Coneally, P.M., Foroud, T. and Nichols, W.C. (2004) Genes influencing Parkinson's disease onset: Replication of PARK3 and identification of novel loci. Neurology, 62, 1616-1618.
19. Li, W., Srinivasula, S.M., Chai, J., Li, P., Wu, J.W., Zhang, Z., Alnemri, E.S. and Shi, Y. (2002) Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi. Nat. Struct. Biol., 9, 436-441.
20. Ghadially, F.N., Yang-Steppuhn, S.E. and Lalonde, J.M. (1982) The effect of uranyl acetate on human lymphoblastoid cells (RPMI 6410) and HeLa cells. Br. J. Exp. Pathol., 63, 227-234.
21. Bancher, C., Grundke-Iqbal, I., Iqbal, K., Kim, K.S. and Wisniewski, H.M. (1989) Immunoreactivity of neuronal lipofuscin with monoclonal antibodies to the amyloid beta-protein. Neurobiol. Aging, 10 125-132.
22. Hicks, A.A., Petursson, H., Jonsson, T., Stefansson, H., Johannsdottir, H.S., Sainz, J., Frigge, M.L., Kong, A., Gulcher, JR., Stefansson, K. et al. (2002) A susceptibility gene for late-onset idiopathic Parkinson disease. Ann. Neurol., 52, 549-555.
23. Bird, T.D., Jarvik, G.P. and Wood, N.W. (2001). Genetic association studies. Neurology, 57, 1153-1154.
24. West, A.B., Zimprich, A., Lockhart, P.J., Farrer, M., Singleton, A., Holtom, B., Lincoln, S., Hofer, A., Hill, L., Muller-Myhsok, B. et al. (2001) Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes. Eur. J. Hum. Genet., 9, 659-666.
25. Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 304, 1158-1160.
26. Bonifati, V., Rizzu, P., Squitieri, F., Krieger, E., Vanacore, N., van Swieten, J.C., Brice, A., van Duijn, C.M., Oostra, B., Meco, G. et al. (2003) DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol. Sci., 24, 159-160.
27. Rathke-Hartlieb, S., Schlomann, U., Heimann, P., Meisler, M.H., Jockusch, H. and Bartsch, J.W. (2002) Progressive loss of striatal neurons causes motor dysfunction in MND2 mutant mice and is not prevented by Bcl-2. Exp. Neurol., 175, 87-97.
28. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605-608.
29. Schon, E.A. and Manfredi, G. (2003) Neuronal degeneration and mitochondrial dysfunction. J. Clin. Invest., 111, 303-312.
30. Sawada, R., Lowe, J.B. and Fukuda, M. (1993) E-selectin-dependent adhesion efficiency of colonic carcinoma cells is increased by genetic manipulation of their cell surface lysosomal membrane glycoprotein-1 expression levels. J. Biol. Chem., 268, 12675-12681.
31. Raymond, M. and Rousset F. (1995) Genepop (version 1.2). population genetics software for exact tests and ecumenicism. J. Hered., 86, 248-249.